Cephalic Mucormycosis (Phycomycosis)
- 1 October 1967
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 17 (4) , 379-386
- https://doi.org/10.1001/archneur.1967.00470280045005
Abstract
MUCORMYCOSIS, or phycomycosis, is a tissue infection by saprophytic fungi of the class Phycomycetes. It occurs in patients with debilitating diseases or following administration of adrenocorticosterioids, antitumor agents, or antibiotics. Patients with diabetic acidosis seem to be especially susceptible to mucormycosis.1 The common sites of initial invasion are the paranasal sinuses, lungs, or gastrointestinal tract. Prior to 1943, 30 cases were collected from the literature, four involving the central nervous system.2 Since 1943, about 160 cases have been reported, 45 with cephalic involvement: paranasal sinus, orbit, cranial nerve, brain, or meninges.3-15 Death directly related to infection occurs in approximately 50% of all cases. To date only eight patients have survived cephalic infection, and all but one had residual neurological deficits (Table). The present report describes the ninth patient who has survived cephalic mucormycosis. Report of a Case This patient (P.H. 159-28-88) had recognized diabetes mellitus sinceThis publication has 6 references indexed in Scilit:
- Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitisJAMA, 1965
- Amphotericin B ToxicityAnnals of Internal Medicine, 1964
- The Improved Prognosis of Cryptococcal Meningitis with Amphotericin B TherapyAnnals of Internal Medicine, 1963
- PHYCOMYCOSIS - A CLINICOPATHOLOGIC STUDY OF 51 CASES1962
- MUCORMYCOSISThe Lancet Healthy Longevity, 1961
- MucormycosisThe American Journal of Medicine, 1960